Evaluating Human Papillomavirus Vaccination Programs
Human papillomavirus (HPV) has been implicated as the primary etiologic agent of cervical cancer. Potential vaccines against high-risk HPV types are in clinical trials. We evaluated vaccination programs with a vaccine against HPV-16 and HPV-18. We developed disease transmission models that estimated...
Auteurs principaux: | , , |
---|---|
Format: | Article |
Langue: | English |
Publié: |
Centers for Disease Control and Prevention
2004-11-01
|
Collection: | Emerging Infectious Diseases |
Sujets: | |
Accès en ligne: | https://wwwnc.cdc.gov/eid/article/10/11/04-0222_article |